Price range: £120.75 through £310.50
IGF-1 DES is an IGF-1 DES peptide created as a shortened and highly active analogue of insulin-like growth factor-1. Researchers use this truncated version to investigate intensified IGF receptor activation, cell-growth responses, and anabolic signaling pathways in vitro. Because the IGF-1 DES peptide exhibits reduced binding to IGF-binding proteins, it enables stronger and more immediate receptor interaction than full-length IGF-1.
Scientists value IGF-1 DES for its ability to strongly influence cellular proliferation, differentiation, and protein synthesis under controlled conditions. It is commonly used in mechanistic studies that explore PI3K/AKT pathway stimulation, regenerative cell behavior, and metabolic growth processes. Additionally, the structural modification allows direct comparison between native IGF-1 activity and enhanced analogues to understand duration, potency, and signaling precision.
Researchers routinely select the IGF-1 DES peptide for:
Studying IGF-1 receptor signaling kinetics
Analysing accelerated cell-proliferation responses
Comparing binding affinity with full-length IGF-1
Investigating short-range autocrine and paracrine pathways
Because IGF-1 DES provides predictable, potent activity, it supports reproducible experiments that require strong receptor engagement and clear downstream response patterns. These characteristics make it ideal for advanced cell-biology, metabolic-pathway, and anabolic-mechanism research.
Our IGF-1 DES peptide is supplied as a high-purity laboratory reagent intended only for qualified scientific professionals. It is not approved for clinical, diagnostic, therapeutic, or veterinary applications. All handling must comply with proper institutional and regulatory guidelines for investigational compounds.
For research use only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.
